What are the optimal treatment courses for geriatric anxiety, and how do we find out?

American Journal of Psychiatry

Volumn 170, Issue 7, 2013, Pages 707-711

  Barlow, David H ^a   Comer, Jonathan S ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PLACEBO;

CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; DISEASE ASSOCIATION; DRUG SAFETY; EVIDENCE BASED PRACTICE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; GERIATRIC PATIENT; HEALTH CARE UTILIZATION; HUMAN; LIFESPAN; MAINTENANCE THERAPY; MENTAL DISEASE; PANIC; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84883190687     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2013.13040513     Document Type: Review

References (14)

1. Wetherell JL, Petkus AJ, White KS, Nguyen H, Kornblith S, Andreescu C, Zisook S, Lenze EJ: Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults. Am J Psychiatry 2013; 170: 782-789
2. Comer JS, Blanco C, Hasin DS, Liu SM, Grant BF, Turner JB, Olfson M: Health-related quality of life across the anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry 2011; 72: 43-50
3. Martens EJ, de Jonge P, Na B, Cohen BE, Lett H, Whooley MA: Scared to death? generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch Gen Psychiatry 2010; 67: 750-758
4. Porensky EK, Dew MA, Karp JF, Skidmore E, Rollman BL, Shear MK, Lenze EJ: The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry 2009; 17: 473-482
5. Lenze EJ, Rollman BL, Shear MK, Dew MA, Pollock BG, Ciliberti C, Costantino M, Snyder S, Shi P, Spitznagel E, Andreescu C, Butters MA, Reynolds CF 3rd: Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA 2009; 301: 295-303
6. Comer JS, Mojtabai R, Olfson M: National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. Am J Psychiatry 2011; 168: 1057-1065
7. Steinberg M, Lyketsos CG: Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry 2012; 169: 900-906
8. White KS, Payne LA, Gorman JM, Shear MK, Woods SW, Saksa JR, Barlow DH: Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? a randomized controlled clinical trial. J Consult Clin Psychol 2013; 81: 47-57
9. Dawson R, Lavori PW: Efficient design and inference for multistage randomized trials of individualized treatment policies. Biostatistics 2012; 13: 142-152
10. Murphy SA: An experimental design for the development of adaptive treatment strategies. Stat Med 2005; 24: 1455-1481
11. Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SAA: A "SMART" design for building individualized treatment sequences. Annu Rev Clin Psychol 2012; 8: 21-48
12. Comer JS, Kendall PC: Methodology, design, and evaluation in psychotherapy research, in Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, 6th ed. Edited by Lambert MJ. Hoboken, NJ, Wiley, 2013
13. Barlow DH, Nock MK, Hersen M: Single case experimental designs: strategies for studying behavior change (3rd ed). New York, Pearson, 2008
14. Roy-Byrne P, Craske MG, Sullivan G, Rose RD, Edlund MJ, Lang AJ, Bystritsky A, Welch SS, Chavira DA, Golinelli D, Campbell-Sills L, Sherbourne CD, Stein MB: Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 2010; 303: 1921-1928